Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pediatrics

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2012-1691PMID 23266923PMCID PMC3529954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• History and Physical Evaluation

  2015cited by this paper
• Propranolol in the treatment of subglottic haemangioma

  2014cited by this paper
• Consensus Conference Initiation and Use of Propranolol for Infantile Hemangioma: Report of a

  2013cited by this paper
• Propranolol for treatment of infantile hemangiomas*

  2013cited by this paper
• Successful Treatment of Infantile Subglottic Hemangioma With Oral Propranolol

  2012cited by this paper
• Stroke in Children With Posterior Fossa Brain Malformations, Hemangiomas, Arterial Anomalies, Coarctation of the Aorta and Cardiac Defects, and Eye Abnormalities (PHACE) Syndrome: A Systematic Review of the Literature

  2012cited by this paper
• Propranolol Induces Regression of Hemangioma Cells Through HIF-1&agr;–Mediated Inhibition of VEGF-A

  2012cited by this paper
• Tumor Lysis Syndrome after Propranolol Therapy in Ulcerative Infantile Hemangioma: Rare Complication or Incidental Finding?

  2012cited by this paper
• Propranolol for Infantile Hemangiomas

  2012cited by this paper
• Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy – a retrospective, single centre study

  2012cited by this paper
• Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.

  2011cited by this paper
• Propranolol as first-line treatment of head and neck hemangiomas.

  2011cited by this paper
• Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.

  2011cited by this paper
• β-Blockers for Infantile Hemangiomas: A Single-Institution Experience

  2011cited by this paper
• An infantile bronchial hemangioma unresponsive to propranolol therapy: case report and literature review.

  2011cited by this paper
• Hepatic Infantile Hemangiomas Treated with Oral Propranolol—A Case Series

  2011cited by this paper
• Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children.

  2011cited by this paper
• Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study

  2011cited by this paper
• Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.

  2011cited by this paper
• Initial Experience With a Multidisciplinary Strategy for Initiation of Propranolol Therapy for Infantile Hemangiomas

  2011cited by this paper
• Propranolol for the Treatment of Orbital Infantile Hemangiomas

  2011cited by this paper
• Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

  2011cited by this paper
• Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?

  2011cited by this paper
• Failure of propranolol in the treatment of childhood haemangiomas of the head and neck

  2011cited by this paper
• Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.

  2011cited by this paper
• Current treatment of parotid hemangiomas

  2011cited by this paper
• Metabolic Profiles in Children During Fasting

  2011cited by this paper
• Hemangiomas of the nasal tip: an approach to a therapeutic challenge.

  2011cited by this paper
• Combined Low-Dose Oral Propranolol and Oral Prednisolone as First-Line Treatment in Periocular Infantile Hemangiomas

  2011cited by this paper
• Propranolol for Infantile Hemangiomas

  2011cited by this paper
• A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas.

  2011cited by this paper
• Propranolol for the treatment of subglottic hemangiomas.

  2011cited by this paper
• Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.

  2011cited by this paper
• Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma

  2011cited by this paper
• Management of complicated facial hemangiomas with Beta-blocker (propranolol) therapy.

  2011cited by this paper
• Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.

  2011cited by this paper
• Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma: A Case Report

  2011cited by this paper
• Effects of β-blocker selectivity on blood pressure variability and stroke

  2011cited by this paper
• Subglottic and mediastinal hemangioma in a child: treatment with propranolol.

  2011cited by this paper
• Low-dose propranolol for infantile haemangioma.

  2011cited by this paper
• Oral propranolol for treatment of periocular infantile hemangiomas.

  2011cited by this paper
• Use of propranolol for treatment of hemangiomas in PHACE syndrome

  2011cited by this paper
• Preliminary results of propranolol treatment for patients with infantile hemangioma.

  2011cited by this paper
• Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome: A New Indication for Propranolol Treatment

  2011cited by this paper
• Hypoglycemia in Children Taking Propranolol for the Treatment of Infantile Hemangioma

  2011cited by this paper
• Propranolol for treatment of ulcerated infantile hemangiomas.

  2011cited by this paper
• Diffuse Infantile Hepatic Hemangiomas: A Report of Four Cases Successfully Managed with Medical Therapy

  2011cited by this paper
• Propranolol treatment for subglottic haemangioma

  2011cited by this paper
• A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

  2011cited by this paper
• Low-Dose Propranolol for Multiple Hepatic and Cutaneous Hemangiomas With Deranged Liver Function

  2011cited by this paper
• Nonselective β-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?

  2011cited by this paper
• Role of propranolol in the management of periocular hemangiomas.

  2010cited by this paper
• Indian J Dermatol Venereol Leprol

  2010cited by this paper
• Diarrhea Associated with Propranolol Treatment for Hemangioma of Infancy (HOI)

  2010cited by this paper
• Propranolol for orbital hemangioma.

  2010cited by this paper
• Dental Caries as a Side Effect of Infantile Hemangioma Treatment with Propranolol Solution

  2010cited by this paper
• Response of infantile hepatic hemangioma to propranolol resistant to high‐dose methylprednisolone and interferon‐α therapy

  2010cited by this paper
• Propranolol Treatment for a Giant Infantile Brain Cavernoma

  2010cited by this paper
• Dramatic response of propranolol in hemangioma: report of two cases.

  2010cited by this paper
• Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.

  2010cited by this paper
• Use of propranolol to treat multicentric airway haemangioma

  2010cited by this paper
• Management of infantile subglottic hemangioma: acebutolol or propranolol?

  2010cited by this paper
• Effectiveness of Propranolol in a Newborn with Liver Hemangiomatosis

  2010cited by this paper
• Propranolol in the management of airway infantile hemangiomas.

  2010cited by this paper
• Propranolol for isolated orbital infantile hemangioma.

  2010cited by this paper
• Hepatic haemangioma of infancy: role of propranolol

  2010cited by this paper
• Propranolol as a Novel Treatment for Congenital Visceral Haemangioma

  2010cited by this paper
• Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

  2010cited by this paper
• Successful treatment of infantile haemangiomas of the orbit with propranolol

  2010cited by this paper
• Sitting in the patient's seat.

  2010cited by this paper
• Current treatments for infantile hemangiomas.

  2010cited by this paper
• Response to Bayliss et al: “Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations”>

  2010cited by this paper
• Hyperkalemia Complicating Propranolol Treatment of an Infantile Hemangioma

  2010cited by this paper
• Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.

  2010cited by this paper
• Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center

  2010cited by this paper
• Use of propranolol in infantile haemangioma among Chinese children.

  2010cited by this paper
• Outpatient treatment of periocular infantile hemangiomas with oral propranolol.

  2010cited by this paper
• Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

  2010cited by this paper
• Propranolol in the management of periorbital infantile haemangioma

  2010cited by this paper
• Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma.

  2010cited by this paper
• Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review

  2010cited by this paper
• Use of propranolol in infantile haemangioma among Chinese children.

  2010cited by this paper
• Erfolgreiche Therapie mit Propranolol bei ausgedehntem Säuglings‐Hämangiom

  2010cited by this paper
• Severe Hypoglycemia During Successful Treatment of Diffuse Hemangiomatosis with Propranolol

  2010cited by this paper
• [Infantile hemangioma. Successful treatment with propranolol].

  2010cited by this paper
• Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.

  2010cited by this paper
• Propranolol for complicated infantile haemangiomas: a case series of 30 infants

  2010cited by this paper
• Management of Complicated Facial Hemangiomas with &bgr;-Blocker (Propranolol) Therapy

  2010cited by this paper
• Initial experience using propranolol as the sole treatment for infantile airway hemangiomas.

  2010cited by this paper
• Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.

  2010cited by this paper
• Case report: Treatment failure using propanolol for treatment of focal subglottic hemangioma.

  2010cited by this paper
• Successful treatment of ulcerated haemangioma with propranolol

  2010cited by this paper
• Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas

  2010cited by this paper
• Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience.

  2010cited by this paper
• Massive response of severe infantile hepatic hemangioma to propanolol

  2010cited by this paper
• Propranolol for infantile haemangiomas and neuroglycopenic seizures

  2010cited by this paper
• [Infantile hemangioma].

  2010cited by this paper
• Propranolol treatment in periocular pediatric patients with hemangiomas.

  2010cited by this paper
• Propranolol as first-line treatment for infantile hemangiomas.

  2010cited by this paper
• The use of propranolol in the treatment of periocular infantile haemangiomas: a review

  2010cited by this paper

• Propranolol Reduces Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Large Retrospective Study

  2026influential citation
• Higher Doses of Oral Propranolol for Resistant Infantile Haemangiomas

  2026cites this paper
• Characteristics and Outcomes of Infantile Hemangioma With Non, Poor, and Partial Response to Standard-Dose Systemic Beta-Blocker Therapy

  2025cites this paper
• Cleft Lip Appearance Secondary to Ulcerating Hemangioma

  2025cites this paper
• Cardiovascular safety of propranolol oral solution in infantile hemangiomas: a disproportionality analysis based on the FAERS database

  2025cites this paper
• The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review

  2025cites this paper
• Paediatric Cardiac Tumours: A National Population Study

  2025cites this paper
• Benign tumors broaden the field of application for immunotherapy

  2025cites this paper
• Efficacy and safety of propranolol tablets vs. oral solution in neonates with severe infantile hemangiomas: a retrospective study in China

  2025cites this paper
• Neonatal Cutaneous Vascular Anomalies.

  2025cites this paper
• Consumptive hypothyroidism complicating infantile hepatic hemangioma successfully treated with propranolol: a case report and literature review

  2025cites this paper
• Infantile Hemangioma Can Cause Serious Complications and the Research Progress of Clinical Treatment Drugs

  2025cites this paper
• Syndromic vascular anomalies: A challenge.

  2025cites this paper
• Platelet indices: a new tool for monitoring infantile hemangioma treatment

  2025influential citation
• From a Facial Hemangioma to a Critical Diagnosis: Uncovering Coarctation of the Aorta in an Infant

  2025cites this paper
• The Efficacy and Safety of Atenolol for Treatment of Infantile Hemangioma

  2025cites this paper
• Infantile hemangioma with cleft lip in a term female infant born to a mother with pregnancy-induced hypertension

  2025cites this paper
• Metronomic Chemotherapy in the Treatment of Infantile Parotid Hemangioma – A Case Report

  2025cites this paper
• Putting LUMBAR on Your Radar.

  2025cites this paper
• Comparative study between oral and intralesional injection of beta-blocker in the treatment of infantile capillary hemangioma

  2025cites this paper
• A report of 12 cases of congenital hepatic hemangioma and literature review

  2025cites this paper
• Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas

  2025cites this paper
• Regimen for accelerated propranolol initial dosing (RAPID)

  2024cites this paper
• Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.

  2024cites this paper
• Optimizing Propranolol Therapy for Infantile Hemangiomas: The Role of the Multidisciplinary Team

  2024cites this paper
• A Systematic Review on Management of Infantile Hemangiomas: How Far We Have Reached in this Past Decade

  2024cites this paper
• Danger et difficultés thérapeutiques des hémangiomes intracrâniens du nourrisson : cas clinique CARE

  2024cites this paper
• Assessing Response Rates and Sleep Disorder Prevalence: Insights from a Propranolol Treatment Study for Infantile Haemangiomas

  2024cites this paper
• Nineteen-Year-Old Woman with Symptomatic Intramuscular Thigh Hemangioma—Radiographic Changes and Management

  2024cites this paper
• PHACE syndrome: A review.

  2024cites this paper
• Dangers and therapeutic difficulties of intracranial hemangioma in infants: A CARE case report.

  2024cites this paper
• Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy

  2024cites this paper
• Infantile Hemangiomas of the Head and Neck: A Single-Center Experience

  2024influential citation
• Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.

  2024cites this paper
• PHACES syndrome‐associated large segmental facial hemangioma successfully treated with oral itraconazole

  2024cites this paper
• The CHIP Score: A Valuable Method for Determining Risk of Surgical Intervention for Hemangioma Patients

  2024cites this paper
• Head and Neck Vascular Anomalies in Children.

  2024cites this paper
• Vascular Mass on the Posterior Neck in a Newborn.

  2024cites this paper
• Use of modified human hemangioma tissue cultures and human umbilical vein endothelial cell cultures to gain mechanistic insights into imiquimod treatment for infantile hemangioma

  2024cites this paper
• Vascular Anomalies Review of the Head and Neck for Physicians in Training

  2024cites this paper
• Paediatric Head and Neck Hemangiomas: Scopes, Challenges and Outcome of Surgical Management

  2024cites this paper
• Microneedle delivery system with rapid dissolution and sustained release of bleomycin for the treatment of hemangiomas

  2024cites this paper
• Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

  2024cites this paper
• Repurposing of antiangiogenic agents for treatment of vascular anomalies.

  2023cites this paper
• Subglottic hemangioma—prevalence, clinical presentation and treatment

  2023cites this paper
• [Advances in the treatment of infantile hemangiomas of the larynx].

  2023cites this paper
• Practice Variations in Managing Infantile Hemangiomas

  2023cites this paper
• Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations

  2023cites this paper
• Tratamento precoce de hemangioma infantil com propranolol melhora o resultado

  2023cites this paper
• Infantile Haemangioma in the Romanian Paediatric Population—Characteristics and Therapeutic Approaches

  2023cites this paper
• Propranolol Therapy for Congenital Chylothorax.

  2023cites this paper
• Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial

  2023cites this paper
• Our experience with propranolol for infantile hemangioma

  2023cites this paper
• Benign and low-grade superficial endothelial cell neoplasms in the molecular era.

  2023cites this paper
• Infantile hemangiomas screening modalities for primary care physicians

  2023cites this paper
• Cardiac side effects of propranolol in infants treated for infantile haemangiomas.

  2023cites this paper
• Management of infantile hemangiomas—experience of a tertiary hospital

  2023influential citation
• Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants

  2023cites this paper
• Clinicoradiological Characteristics and Outcome of Three Patients with PHACES Syndrome Associated with Intracranial Arteriopathy

  2023influential citation
• Indications for surgical resection of complicated infantile hemangiomas in the β-blocker’s era: a single-institution experience from a retrospective cohort study

  2023cites this paper
• Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1.

  2023cites this paper
• Beard neonatal hemangioma: report of a PHACE syndrome

  2023influential citation
• Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study.

  2023cites this paper
• Propranolol or Beta-Blockers for Cerebral Cavernous Malformation: a Systematic Review and Meta-analysis of Literature in Both Preclinical and Clinical Studies

  2023cites this paper
• Eyelid, Orbital, and Lacrimal Disorders in the Neonate.

  2023cites this paper
• Cardiac screening in patients with infantile hemangiomas before propranolol treatment

  2023influential citation
• Propranolol for Vascular Anomalies: Efficacy and Complications in Pediatric Patients

  2023cites this paper
• Society for Pediatric Dermatology 48th Annual Meeting Poster Abstracts Presented in Asheville, North Carolina, 11 to 14 July 2023

  2023cites this paper
• Congenital Neck Masses.

  2023cites this paper
• Connecting academia and industry for innovative drug repurposing in rare diseases: it is worth a try

  2023cites this paper
• Global research trends of infantile hemangioma: A bibliometric and visualization analysis from 2000 to 2022

  2023cites this paper
• Lasers for cutaneous lesions: An update

  2022cites this paper
• Severe hypoglycemia in propranolol treatment for infantile hemangiomas

  2022cites this paper
• Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study

  2022cites this paper
• Infantile Hemangioma and Cardiac Defects: a Puzzling Association. A Single-center Experience

  2022cites this paper
• The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas.

  2022cites this paper
• Inter‐ and intra‐observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain

  2022cites this paper
• Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study

  2022cites this paper
• Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects

  2022cites this paper
• Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age

  2022cites this paper
• Surgical management of large scalp infantile hemangioma in 30-month-old infant.

  2022cites this paper
• New approaches for solving the old problem

  2022cites this paper
• Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China

  2022cites this paper
• Propranolol-induced hyperkalemia in infantile hemangioma patients: How serious is it?

  2022cites this paper
• Oral propranolol and topical timolol in the treatment of post‐burn pyogenic granuloma: Two cases and a review of the literature

  2022cites this paper
• Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.

  2022cites this paper
• FORMATION OF DEEP INFANTILE HEMANGIOMA AGAINST THE BACKGROUND OF CONGENITAL HERPES VIRUS INFECTION

  2022cites this paper
• Apelin Receptor can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.

  2022cites this paper
• Bleomycin-Triamcinolone sclerotherapy in the management of propranolol resistant infantile hemangioma of the maxillofacial region: A single arm prospective evaluation of clinical outcome and Doppler ultrasound parameters.

  2022cites this paper
• Prophylactic Propranalol In Prevention of Retinopathy of Prematurity in Premature Neonates

  2022cites this paper
• Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study

  2022cites this paper
• Vascular anomalies

  2022cites this paper
• Monitoring oral propranolol for infantile hemangiomata

  2022cites this paper
• Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

  2022cites this paper
• Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument

  2022cites this paper
• [Management of ulcers on a segmental hemangioma: A combination of systemic and topical therapies in two pediatric cases].

  2022cites this paper
• Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019

  2022cites this paper
• Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.

  2021cites this paper
• Application value of computer-assisted surgery system in pediatric hepatic hemangioma

  2021cites this paper
• Hemanjiyomu Nedeniyle Propranolol Tedavisi Verilen Çocuklarda Tek Lokalizasyon veya Çoklu Lokalizasyon ile Prognoz Arasındaki İlişkinin Değerlendirilmesi

  2021cites this paper